News

June 22, 2020

Research report about Solasia was updated by Shared Research Inc.

June 15, 2020

Solasia Announces Positive Results of DARINAPARSIN in Pivotal Phase 2 Study for Peripheral T-Cell Lymphoma (PDF 145 KB)

May 14, 2020

Business Overview of Pipeline Products (First Quarter of the Fiscal Year Ending December 31, 2020) (PDF 318 KB)

May 14, 2020

Consolidated Financial Results for the First Three Months of the Fiscal Year Ending December 31, 2020 (under IFRS) (PDF 282 KB)

April 15, 2020

IR Report (Bridge Report) about Solasia

April 6, 2020

Update on SP-04 (PledOx) (3rd Report) (PDF 114 KB)

March 30, 2020

Notice of the Resolutions Adopted at the 12th Annual General Meeting of Shareholders (PDF 48 KB)

March 26, 2020

Research report about Solasia was updated by Shared Research Inc.

March 13, 2020

Notice of the 12th Annual General Meeting of Shareholders (PDF 235 KB)

March 2, 2020

PledPharma Announces Update on SP-04 (PledOx) Clinical Study Information (PDF 72 KB)

February 27, 2020

Announcement Regarding Changes to Executive Management and Conclusion of New Business Agreement with Itochu (PDF 123 KB)

February 13, 2020

Business Overview of Pipeline Products (Fiscal Year Ended December 31, 2019) (PDF 314 KB)

February 13, 2020

Consolidated Financial Results for the Fiscal Year Ended December 31, 2019 (under IFRS) (PDF 421 KB)

January 30, 2020

Solasia Announces Exclusive Out-Licensing Agreement for episil oral liquid with Synex in South Korea (PDF 168 KB)

January 23, 2020

PledPharma AB Announces Update on SP-04 (PledOx) Clinical Study Information (PDF 69 KB)

January 6, 2020

Solasia Selected as a Loan Margin Trading Issue (PDF 70 KB)